Redox Metals and Catecholamines in Neurodegenerative Diseases

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 291

Special Issue Editors


E-Mail Website
Guest Editor
Dipartimento di Chimica, Università di Pavia, Via Taramelli 12, 27100 Pavia, Italy
Interests: redox chemistry; neurodegenerative diseases; neurodegeneration

E-Mail
Guest Editor
Dipartimento di Chimica, Università di Pavia, Via Taramelli 12, 27100 Pavia, Italy
Interests: metal complexes; coordination chemistry; catalysis; neurodegeneration

Special Issue Information

Dear Colleagues,

Alteration in metal levels is detected in different pathophysiological mechanisms associated with neurodegenerative disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS). The imbalance of some essential metals, including zinc (Zn), copper (Cu), iron (Fe) and manganese (Mn), compromises structures and functions of several proteins and enzymes, promoting neurotoxicity, mitochondrial dysregulation and cell death. Another pathological mechanism usually reviewed as pivotal in neurodegeneration involves catecholamine oxidation-derived neurodamage. Catecholamines such as dopamine, epinephrine and norepinephrine are reactive molecules prone to undergo dioxygen-dependent self-oxidation and metal-catalyzed oxidation. These oxidative pathways can give rise to unspecific protein modifications, resulting in structural misfolding, inactivation and aggregation into insoluble neuro-deposits.

This Special Issue aims to provide the basis for a better understanding of the metals and catecholamine-related biochemical mechanisms that trigger these neurodisorders. We invite investigators to submit original papers focused on the topics outlined below:

  • Catecholamine reactivity and interplay with redox active metals
  • Catecholamine oxidative products and metals as neuronal biomarkers
  • Catecholamine-mediated modification of proteins and peptides
  • Neuroinflammation promoted by trace metals
  • Recent advances in drug discovery based on metal and catecholamine-related pathways.

Prof. Dr. Enrico Monzani
Dr. Chiara Bacchella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodegeneration
  • catecholamines
  • redox metals
  • oxidative stress
  • protein modification

Published Papers

This special issue is now open for submission.
Back to TopTop